Mark Kane

5.8k total citations · 1 hit paper
65 papers, 3.4k citations indexed

About

Mark Kane is a scholar working on Epidemiology, Hepatology and Health. According to data from OpenAlex, Mark Kane has authored 65 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Epidemiology, 32 papers in Hepatology and 23 papers in Health. Recurrent topics in Mark Kane's work include Hepatitis B Virus Studies (41 papers), Hepatitis Viruses Studies and Epidemiology (26 papers) and Vaccine Coverage and Hesitancy (22 papers). Mark Kane is often cited by papers focused on Hepatitis B Virus Studies (41 papers), Hepatitis Viruses Studies and Epidemiology (26 papers) and Vaccine Coverage and Hesitancy (22 papers). Mark Kane collaborates with scholars based in United States, Switzerland and China. Mark Kane's co-authors include Stephen C. Hadler, Quing Zhu, Scott H. Kurtzman, Susan Tannenbaum, Poornima Hegde, James E. Maynard, Nanguang Chen, Bipin Jagjivan, Minming Huang and Xu Chen and has published in prestigious journals such as The Lancet, JAMA and Annals of Internal Medicine.

In The Last Decade

Mark Kane

63 papers receiving 3.2k citations

Hit Papers

The good research guide for small-scale social research p... 1999 2026 2008 2017 1999 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Kane United States 27 1.2k 821 570 529 353 65 3.4k
Wolfgang Preiser South Africa 41 1.4k 1.1× 461 0.6× 234 0.4× 161 0.3× 3.4k 9.5× 217 6.6k
Michael Edelstein United Kingdom 36 1.2k 1.0× 236 0.3× 164 0.3× 265 0.5× 1.1k 3.0× 189 7.0k
Adam Finn United Kingdom 53 3.5k 2.9× 156 0.2× 110 0.2× 254 0.5× 1.1k 3.1× 326 10.2k
David R. Kaufman United States 36 385 0.3× 70 0.1× 200 0.4× 174 0.3× 386 1.1× 176 7.2k
David R. Karp United States 44 529 0.4× 59 0.1× 781 1.4× 245 0.5× 573 1.6× 153 6.2k
Joan Robinson Canada 42 2.8k 2.3× 136 0.2× 117 0.2× 114 0.2× 1.3k 3.7× 278 8.4k
Michael G. Hudgens United States 46 3.0k 2.4× 267 0.3× 115 0.2× 114 0.2× 3.3k 9.4× 293 8.7k
Jian Wang China 34 1.0k 0.9× 562 0.7× 152 0.3× 36 0.1× 513 1.5× 217 5.1k
Sue E. Crawford United States 58 2.5k 2.0× 793 1.0× 141 0.2× 383 0.7× 6.8k 19.2× 134 11.4k
Vincent C. Marconi United States 43 1.8k 1.5× 228 0.3× 98 0.2× 150 0.3× 3.5k 10.0× 258 8.7k

Countries citing papers authored by Mark Kane

Since Specialization
Citations

This map shows the geographic impact of Mark Kane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kane more than expected).

Fields of papers citing papers by Mark Kane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Kane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kane. The network helps show where Mark Kane may publish in the future.

Co-authorship network of co-authors of Mark Kane

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Kane. A scholar is included among the top collaborators of Mark Kane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Kane. Mark Kane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mazonson, Peter, et al.. (2020). Loneliness among older adults living with HIV: the “older old” may be less lonely than the “younger old”. AIDS Care. 33(3). 375–382. 24 indexed citations
2.
Kane, Mark, Evan M. Bloch, Roberta Bruhn, Zhanna Kaidarova, & Edward L. Murphy. (2015). Demographic determinants of syphilis seroprevalence among U.S. blood donors, 2011–2012. BMC Infectious Diseases. 15(1). 63–63. 26 indexed citations
3.
Liang, Xiaofeng, Fuqiang Cui, Stephen C. Hadler, et al.. (2013). Origins, design and implementation of the China GAVI project. Vaccine. 31. J8–J14. 30 indexed citations
4.
Wu, Zhenhua, Fuqiang Cui, Yuansheng Chen, et al.. (2013). Evaluation of immunization injection safety in China, 2010: Achievements, future sustainability. Vaccine. 31. J43–J48. 14 indexed citations
5.
Kane, Mark, Beatriz Serrano, Silvia de Sanjosé, & Scott Wittet. (2012). Implementation of Human Papillomavirus Immunization in the Developing World. Vaccine. 30. F192–F200. 55 indexed citations
6.
Kane, Mark. (2010). Global implementation of human papillomavirus (HPV) vaccine: Lessons from hepatitis B vaccine. Gynecologic Oncology. 117(2). S32–S35. 21 indexed citations
7.
Zhu, Quing, Poornima Hegde, Andrew Ricci, et al.. (2010). Early-Stage Invasive Breast Cancers: Potential Role of Optical Tomography with US Localization in Assisting Diagnosis. Radiology. 256(2). 367–378. 91 indexed citations
8.
Andrus, Jon Kim, Jacqueline Sherris, John W. Fitzsimmons, Mark Kane, & M. Teresa Aguado. (2008). Introduction of Human Papillomavirus Vaccines into Developing Countries - International Strategies for Funding and Procurement. Vaccine. 26. K87–K92. 40 indexed citations
9.
Kane, Mark, John Holt, & Brian Allen. (2004). Results concerning the generalized partially linear single-index model. Journal of Statistical Computation and Simulation. 74(12). 897–912. 2 indexed citations
10.
Zhu, Quing, Minming Huang, Nanguang Chen, et al.. (2003). Ultrasound-Guided Optical Tomographic Imaging of Malignant and Benign Breast Lesions: Initial Clinical Results of 19 Cases. Neoplasia. 5(5). 379–388. 128 indexed citations
11.
Kane, Mark, et al.. (2002). New immunization initiatives and progress toward the global control of hepatitis B. Current Opinion in Infectious Diseases. 15(5). 465–469. 33 indexed citations
12.
Kane, Mark. (1995). Implementing universal vaccination programmes: USA. Vaccine. 13. S75–S76. 11 indexed citations
13.
Kane, Mark. (1995). Global programme for control of hepatitis B infection. Vaccine. 13. S47–S49. 324 indexed citations
14.
Kane, Mark. (1992). Perspectives on the control of hepatitis A by vaccination. Vaccine. 10. S93–S96. 11 indexed citations
15.
Maynard, James E., Mark Kane, & Stephen C. Hadler. (1989). Global Control of Hepatitis B Through Vaccination: Role of Hepatitis B Vaccine in the Expanded Programme on Immunization. Clinical Infectious Diseases. 11(Supplement_3). S574–S578. 123 indexed citations
16.
Shapiro, Craig N., Linda F. McCaig, Kathleen F. Gensheimer, et al.. (1989). Hepatitis B virus transmission between children in day care. The Pediatric Infectious Disease Journal. 8(12). 870–875. 30 indexed citations
17.
Kane, Mark. (1988). Routine Prenatal Screening for Hepatitis B Surface Antigen. JAMA. 259(3). 408–408. 18 indexed citations
18.
Berry, Arnold J., Mark Kane, Gary C. Schatz, et al.. (1985). A Multicenter Study of the Epidemiology of Hepatitis B in Anesthesia Residents. Anesthesia & Analgesia. 64(7). 672???676–672???676. 12 indexed citations
19.
Berry, Arnold J., et al.. (1984). A Multicenter Study of the Prevalence of Hepatitis B Viral Serologic Markers in Anesthesia Personnel. Anesthesia & Analgesia. 63(8). 738???742–738???742. 9 indexed citations
20.
Mann, Jonathan M., Mark Kane, & Harry F. Hull. (1983). Hepatitis B, hepatitis B vaccine and education for the handicapped. The Pediatric Infectious Disease Journal. 2(4). 273–275. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026